Promising Phase 3 Results for Epcoritamab Combined with R-CHOP in DLBCL Treatment #USA #Epcoritamab #AbbVie #North_Chicago #DLBCL
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialAbbVie Announces Approval for Epcoritamab in Combination Therapy for Follicular Lymphoma #Japan #Follicular_Lymphoma #Epcoritamab #AbbVie #Minato-ku,_Tokyo